Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 26% ± 9% | |
ciliated cell | 3 studies | 22% ± 6% |
Insufficient scRNA-seq data for expression of PRMT5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2014.27 | 1445 / 1445 | 100% | 27.11 | 183 / 183 |
ovary | 100% | 2450.48 | 180 / 180 | 100% | 34.49 | 429 / 430 |
stomach | 100% | 1490.01 | 359 / 359 | 99% | 28.15 | 284 / 286 |
intestine | 100% | 1731.13 | 966 / 966 | 99% | 32.63 | 522 / 527 |
lung | 100% | 1542.18 | 576 / 578 | 99% | 25.04 | 1147 / 1155 |
breast | 100% | 1925.25 | 459 / 459 | 98% | 26.63 | 1094 / 1118 |
skin | 100% | 2632.04 | 1809 / 1809 | 97% | 28.43 | 460 / 472 |
pancreas | 100% | 1103.80 | 327 / 328 | 98% | 17.87 | 174 / 178 |
prostate | 100% | 1691.51 | 245 / 245 | 97% | 23.24 | 487 / 502 |
brain | 97% | 1108.82 | 2562 / 2642 | 99% | 29.46 | 701 / 705 |
bladder | 100% | 1976.24 | 21 / 21 | 95% | 25.02 | 480 / 504 |
uterus | 100% | 2205.88 | 170 / 170 | 95% | 25.06 | 437 / 459 |
thymus | 100% | 2051.63 | 653 / 653 | 95% | 18.32 | 572 / 605 |
kidney | 100% | 1594.16 | 89 / 89 | 90% | 16.76 | 814 / 901 |
adrenal gland | 100% | 1910.98 | 258 / 258 | 76% | 9.72 | 174 / 230 |
liver | 96% | 834.36 | 218 / 226 | 79% | 9.50 | 321 / 406 |
adipose | 100% | 1727.94 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1700.40 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 2702.02 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1515.66 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 25.43 | 45 / 45 |
eye | 0% | 0 | 0 / 0 | 98% | 24.96 | 78 / 80 |
heart | 93% | 1307.99 | 805 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 90% | 1800.33 | 837 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 22.63 | 26 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0070372 | Biological process | regulation of ERK1 and ERK2 cascade |
GO_0000387 | Biological process | spliceosomal snRNP assembly |
GO_0044027 | Biological process | negative regulation of gene expression via chromosomal CpG island methylation |
GO_0048026 | Biological process | positive regulation of mRNA splicing, via spliceosome |
GO_0042118 | Biological process | endothelial cell activation |
GO_0006338 | Biological process | chromatin remodeling |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0018216 | Biological process | peptidyl-arginine methylation |
GO_0097421 | Biological process | liver regeneration |
GO_0048714 | Biological process | positive regulation of oligodendrocyte differentiation |
GO_1901796 | Biological process | regulation of signal transduction by p53 class mediator |
GO_0035246 | Biological process | peptidyl-arginine N-methylation |
GO_1904992 | Biological process | positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0045596 | Biological process | negative regulation of cell differentiation |
GO_0006353 | Biological process | DNA-templated transcription termination |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0090161 | Biological process | Golgi ribbon formation |
GO_0007088 | Biological process | regulation of mitotic nuclear division |
GO_0035097 | Cellular component | histone methyltransferase complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0034709 | Cellular component | methylosome |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0035243 | Molecular function | protein-arginine omega-N symmetric methyltransferase activity |
GO_0043021 | Molecular function | ribonucleoprotein complex binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0042054 | Molecular function | histone methyltransferase activity |
GO_0008327 | Molecular function | methyl-CpG binding |
GO_0002039 | Molecular function | p53 binding |
GO_0008168 | Molecular function | methyltransferase activity |
GO_0008469 | Molecular function | histone arginine N-methyltransferase activity |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0016274 | Molecular function | protein-arginine N-methyltransferase activity |
GO_0140938 | Molecular function | histone H3 methyltransferase activity |
GO_0070888 | Molecular function | E-box binding |
GO_0044020 | Molecular function | histone H4R3 methyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PRMT5 |
Protein name | Protein arginine methyltransferase 5 Protein arginine N-methyltransferase 5 (PRMT5) (EC 2.1.1.320) (72 kDa ICln-binding protein) (Histone-arginine N-methyltransferase PRMT5) (Jak-binding protein 1) (Shk1 kinase-binding protein 1 homolog) (SKB1 homolog) (SKB1Hs) [Cleaved into: Protein arginine N-methyltransferase 5, N-terminally processed] |
Synonyms | HRMT1L5 IBP72 JBP1 SKB1 |
Description | FUNCTION: Arginine methyltransferase that can both catalyze the formation of omega-N monomethylarginine (MMA) and symmetrical dimethylarginine (sDMA), with a preference for the formation of MMA . Specifically mediates the symmetrical dimethylation of arginine residues in the small nuclear ribonucleoproteins Sm D1 (SNRPD1) and Sm D3 (SNRPD3); such methylation being required for the assembly and biogenesis of snRNP core particles . Methylates SUPT5H and may regulate its transcriptional elongation properties . May methylate the N-terminal region of MBD2 . Mono- and dimethylates arginine residues of myelin basic protein (MBP) in vitro. May play a role in cytokine-activated transduction pathways. Negatively regulates cyclin E1 promoter activity and cellular proliferation. Methylates histone H2A and H4 'Arg-3' during germ cell development (By similarity). Methylates histone H3 'Arg-8', which may repress transcription (By similarity). Methylates the Piwi proteins (PIWIL1, PIWIL2 and PIWIL4), methylation of Piwi proteins being required for the interaction with Tudor domain-containing proteins and subsequent localization to the meiotic nuage (By similarity). Methylates RPS10. Attenuates EGF signaling through the MAPK1/MAPK3 pathway acting at 2 levels. First, monomethylates EGFR; this enhances EGFR 'Tyr-1197' phosphorylation and PTPN6 recruitment, eventually leading to reduced SOS1 phosphorylation . Second, methylates RAF1 and probably BRAF, hence destabilizing these 2 signaling proteins and reducing their catalytic activity . Required for induction of E-selectin and VCAM-1, on the endothelial cells surface at sites of inflammation. Methylates HOXA9 . Methylates and regulates SRGAP2 which is involved in cell migration and differentiation . Acts as a transcriptional corepressor in CRY1-mediated repression of the core circadian component PER1 by regulating the H4R3 dimethylation at the PER1 promoter (By similarity). Methylates GM130/GOLGA2, regulating Golgi ribbon formation . Methylates H4R3 in genes involved in glioblastomagenesis in a CHTOP- and/or TET1-dependent manner . Symmetrically methylates POLR2A, a modification that allows the recruitment to POLR2A of proteins including SMN1/SMN2 and SETX. This is required for resolving RNA-DNA hybrids created by RNA polymerase II, that form R-loop in transcription terminal regions, an important step in proper transcription termination . Along with LYAR, binds the promoter of gamma-globin HBG1/HBG2 and represses its expression . Symmetrically methylates NCL . Methylates p53/TP53; methylation might possibly affect p53/TP53 target gene specificity . Involved in spliceosome maturation and mRNA splicing in prophase I spermatocytes through the catalysis of the symmetrical arginine dimethylation of SNRPB (small nuclear ribonucleoprotein-associated protein) and the interaction with tudor domain-containing protein TDRD6 (By similarity). . |
Accessions | H0YJY6 G3V2L6 ENST00000627278.1 G3V507 ENST00000557415.5 ENST00000556616.5 ENST00000553502.5 H0YJX6 C9JSX3 ENST00000555530.5 G3V5L5 G3V2X6 H0YJD3 G3V5T6 ENST00000554867.5 ENST00000421938.2 ENST00000216350.12 [O14744-3] ENST00000557443.5 ENST00000324366.13 [O14744-1] G3V2F5 G3V3A3 ENST00000553915.5 G3V580 H0YJ77 ENST00000454731.6 ENST00000553897.5 [O14744-5] ENST00000553787.5 ENST00000555454.5 ENST00000554910.5 ENST00000553550.5 ENST00000397440.8 [O14744-4] ENST00000397441.6 [O14744-2] H7BZ44 ENST00000556043.5 O14744 |